In an article published on Feb. 9, 2024, by The Washington Post, Fort Lauderdale managing partner Gabriel Imperato shared his thoughts on the alleged $2 billion Medicare fraud scheme that involves seven companies accused of submitting fraudulent insurance claims targeting urinary catheters that patients neither ordered nor received. The scale of the alleged scheme is estimated at $2 billion.

The episode underscores the frequent fraud in the field of durable medical equipment, where repeat offenders have learned to set up shell companies and exploit loopholes, Imperato told The Washington Post. Imperato added that government officials face hurdles in trying to combat fraud, given the sheer number of complaints, the confidentiality of investigations, and the years it can take to assemble and prosecute a case, the publication wrote.

Read the full article here.